• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Double Left Left Jul / 2026 Right Double Right
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI

Prostate Cancer: New ESTRO Recommendations for Precision Radiotherapy

Monica Bertagnolli: Don't Abolish the NIH, Fix It

Can SABR Replace Surgery in Selected Low-Risk Breast Cancer?

BOT/BAL Shows 33% 3-Year OS in Refractory MSS mCRC Without Active Liver Metastases

Daraxonrasib for Pancreatic Cancer: What’s Next?

ESTRO Sets Practical Guidance for Focal Boosting in Prostate Cancer Radiotherapy 2026

Felicia Marie Knaul: WHO to Present First Global Estimates of 5-Year Breast Cancer Survival

OncoCalendar

16 events found.

European Society For Medical Oncology (ESMO)

« All Events
Phone +41 (0)91 973 19 00
Email esmo@esmo.org
Website https://www.esmo.org/

Events from this organizer

Today
  • March 2026

  • Wed 11
    ESMO - The Christie Preceptorship

    ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester

    Mar 11 - Mar 13
    Manchester, United Kingdom

    The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […]

  • Thu 12
    ESMO

    The ESMO Sarcoma and Rare Cancers Congress 2026

    Mar 12 • 8:00 AM - Mar 14 • 5:00 PM
    “Palazzo dei Congressi” in Lugano, Switzerland Piazza Indipendenza 4, Lugano, Switzerland

    The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […]

  • Mon 16
    ESMO TAT

    ESMO Targeted Anticancer Therapies Congress 2026

    Mar 16 - Mar 18
    Palais des Congrès de Paris 2 Pl de la Pte Maillot, Paris, Île-de-France, France

    The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development. The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The […]

  • Thu 19
    The ICHNO 2026

    The ICHNO 2026

    Mar 19 • 8:00 AM - Mar 21 • 5:00 PM
    Fibes - Conference and Exhibition Ave. Alcalde Luis Uruñuela, 1, Seville, Spain

    The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by […]

  • Wed 25
    ESMO Guidelines

    ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026

    Mar 25
    Virtual Event

    The ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25, 2026, focused on the practical application of clinical […]

  • Wed 25
    ELCC 2026

    The European Lung Cancer Congress (ELCC 2026)

    Mar 25 • 8:00 AM - Mar 28 • 5:00 PM
    Bella Center Center Boulevard 5, Copenhagen, Denmark

    The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as […]

  • Fri 27
    ESMO Advanced Course

    ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing

    Mar 27 - Mar 28
    Beijing, China

    The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled […]

  • April 2026

  • Wed 1
    ESMO Deep Dive

    ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026

    Apr 1
    Virtual Event

    The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar, scheduled for April 1, 2026, focuses on the integration of precision diagnostics and […]

  • Wed 15
    Toxicity of Cellular Therapies, ESMO Therapeutic Landscapes

    ESMO Therapeutic Landscapes Webinar: Tumour Agnostics 2026

    Apr 15
    Virtual Event

    The ESMO Therapeutic Landscapes Webinar: Tumour Agnostics 2026 is a specialized virtual session scheduled for Wednesday, April 15, 2026, from 18:30 to 19:30 CEST. Part of a new educational series designed to keep oncology professionals at the forefront of emerging management strategies, this webinar focuses on the shift toward treating cancers based on specific molecular […]

  • Wed 15
    Preceptorship on Gastroesophageal Cancer

    ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota

    Apr 15 - Apr 16
    Bogota, Colombia

    The ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota is a two-day educational course aimed primarily at oncologists resident in Latin America. It will be held from April 15–16, 2026, in Bogota, Colombia. The application deadline for this preceptorship is February 1, 2026, at 23:59 CET. Successful applicants receive complimentary course registration and accommodation, and a […]

  • Wed 15
    ESMO Preceptorship on Breast Cancer

    ESMO Preceptorship on Breast Cancer 2026: Bogota

    Apr 15 - Apr 16
    Bogota, Colombia

    The ESMO Preceptorship on Breast Cancer 2026: Bogota is an educational course scheduled for April 15–16, 2026, in Bogotá, Colombia. Co-chaired by Carlos Barrios and Nadia Harbeck, this intensive meeting is primarily aimed at oncologists in Latin America to foster interdisciplinary collaboration and improve subtype-specific breast cancer management. The technical program covers the latest advancements […]

  • Fri 17
    ESMO Summit Latin America

    ESMO Summit Latin America 2026

    Apr 17 - Apr 18
    Hilton Bogota Corferias Carrera 37 No. 24 29, Bogotá, Bogotá D.C., Colombia

    The ESMO Summit Latin America 2026 is a premier educational meeting scheduled for April 17-18, 2026, in Bogotá, Colombia. Organized by the European Society for Medical Oncology (ESMO) in collaboration […]

  • Thu 23
    ESMO Advanced Course

    ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026: Athens

    Apr 23 - Apr 24
    Athens, Greece

    The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24, 2026, in Athens, Greece. Under the leadership […]

  • Wed 29
    ESMO Guidelines

    ESMO Guidelines: Real World Cases – Webinar Series: Bladder Cancer 2026

    Apr 29
    Virtual Event

    The ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29, 2026, focused on translating the latest ESMO Clinical […]

  • May 2026

  • Wed 6
    ESMO Deep Dive

    ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026

    May 6
    Virtual Event

    The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6, 2026. This session focuses on the clinical […]

  • Wed 6
    ESMO, Abstract

    The ESMO Breast Cancer 2026

    May 6 • 8:00 AM - May 8 • 5:00 PM
    Messe Berlin Messedamm 22, Berlin, Germany

    Join the global breast cancer community at ESMO Breast Cancer 2026, taking place from 6 to 8 May 2026 in Berlin, Germany, or online. This international congress will gather top […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer ASCO fight against cancer cancer care Global fight against cancer Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC cancer treatment MD Anderson Cancer Center cancer awareness colorectal cancer clinical trials Research Childhood Cancer prostate cancer ASCO24 FDA AACR UICC Dana-Farber Cancer Institute chemotherapy American Cancer Society Pancreatic Cancer SIOP European Cancer Organisation Robert Orlowski radiation oncology American Society of Clinical Oncology Myeloma Paper of the Day Paolo Tarantino AI NCI Vivek Subbiah National Cancer Institute Myeloma cervical cancer WHO IASLC radiotherapy healthcare Memorial Sloan Kettering Cancer Center bladder cancer multiple myeloma

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}